Phase II Study of Neoadjuvant Bevacizumab and Radiation Therapy for Resectable Soft Tissue Sarcomas

PURPOSE: Numerous preclinical studies demonstrate that angiogenesis inhibitors can increase the efficacy of radiation therapy (RT). We sought to examine safety and efficacy of bevacizumab (BV) and RT in soft tissue sarcomas (STS) and explore biomarkers for treatment response. METHODS AND MATERIALS:...

詳細記述

保存先:
書誌詳細
主要な著者: Yoon, Sam S., Duda, Dan G., Karl, Daniel L., Kim, Tae-Min, Kambadakone, Avinash R., Chen, Yen-Lin, Rothrock, Courtney, Rosenberg, Andrew E., Nielsen, G. Petur, Kirsch, David G., Choy, Edwin, Harmon, David C, Hornicek, Francis J., Dreyfuss, Jonathan, Ancukiewicz, Marek, Sahani, Dushyant V., Park, Peter J., Jain, Rakesh K., DeLaney, Thomas F.
フォーマット: Artigo
言語:Inglês
出版事項: 2010
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3021107/
https://ncbi.nlm.nih.gov/pubmed/20932656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.07.024
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料